Moreover, Jiang et al. demonstrated that EGLN3 (egl-9 family hypoxia-inducible factor 3 gene) and c-Myc activate Lyme-specific helicase (LSH) in lung cancer by inhibiting HIF-1α (hypoxia-inducible factor-1α) [79]. This evidence concerns the gene MYC and lung carcinoma.